The Potential Impact of AMAROS on the Management of the Axilla in Patients with Clinical T1-2N0 Breast Cancer Undergoing Primary Total Mastectomy

The Potential Impact of AMAROS on the Management of the Axilla in Patients with Clinical T1-2N0... Ann Surg Oncol (2018) 25:2612–2619 https://doi.org/10.1245/s10434-018-6519-1 OR IG INA L A R TIC L E – BREA S T O NC OLOG Y The Potential Impact of AMAROS on the Management of the Axilla in Patients with Clinical T1-2N0 Breast Cancer Undergoing Primary Total Mastectomy 1 2,3 4 4 5 Martine Moossdorff, MD , Faina Nakhlis, MD , Jiani Hu, MPH , William T. Barry, PhD , Katya Losk, MPH , 2 1 2,3 Courtney Haskett , Marjolein L. Smidt, MD, PhD , and Tari A. King, MD Department of Surgery, GROW School for Oncology and Developmental Biology, Maastricht University Medical Center, 2 3 Maastricht, The Netherlands; Department of Surgery, Brigham and Women’s Hospital, Boston, MA; Dana-Farber/ Brigham and Women’s Cancer Center, Boston, MA; Department of Biostatistics and Computational Biology, Dana- Farber Cancer Institute, Boston, MA; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA ABSTRACT nodes. In the multivariate analysis, age younger than Background. Recent trials have demonstrated that axil- 50 years (odds ratio [OR] 3.55; 95% confidence interval lary observation or axillary radiation therapy (AxRT) is [CI] 1.57–8.45), lymphovascular invasion (LVI) (OR equivalent to axillary node dissection (ALND) for patients 5.78; 95% CI 2.53–4.78), macrometastases (OR 3.99; with one http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Annals of Surgical Oncology Springer Journals

The Potential Impact of AMAROS on the Management of the Axilla in Patients with Clinical T1-2N0 Breast Cancer Undergoing Primary Total Mastectomy

Loading next page...
 
/lp/springer_journal/the-potential-impact-of-amaros-on-the-management-of-the-axilla-in-vJRuVz3B06
Publisher
Springer Journals
Copyright
Copyright © 2018 by Society of Surgical Oncology
Subject
Medicine & Public Health; Surgical Oncology; Oncology; Surgery
ISSN
1068-9265
eISSN
1534-4681
D.O.I.
10.1245/s10434-018-6519-1
Publisher site
See Article on Publisher Site

Abstract

Ann Surg Oncol (2018) 25:2612–2619 https://doi.org/10.1245/s10434-018-6519-1 OR IG INA L A R TIC L E – BREA S T O NC OLOG Y The Potential Impact of AMAROS on the Management of the Axilla in Patients with Clinical T1-2N0 Breast Cancer Undergoing Primary Total Mastectomy 1 2,3 4 4 5 Martine Moossdorff, MD , Faina Nakhlis, MD , Jiani Hu, MPH , William T. Barry, PhD , Katya Losk, MPH , 2 1 2,3 Courtney Haskett , Marjolein L. Smidt, MD, PhD , and Tari A. King, MD Department of Surgery, GROW School for Oncology and Developmental Biology, Maastricht University Medical Center, 2 3 Maastricht, The Netherlands; Department of Surgery, Brigham and Women’s Hospital, Boston, MA; Dana-Farber/ Brigham and Women’s Cancer Center, Boston, MA; Department of Biostatistics and Computational Biology, Dana- Farber Cancer Institute, Boston, MA; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA ABSTRACT nodes. In the multivariate analysis, age younger than Background. Recent trials have demonstrated that axil- 50 years (odds ratio [OR] 3.55; 95% confidence interval lary observation or axillary radiation therapy (AxRT) is [CI] 1.57–8.45), lymphovascular invasion (LVI) (OR equivalent to axillary node dissection (ALND) for patients 5.78; 95% CI 2.53–4.78), macrometastases (OR 3.99; with one

Journal

Annals of Surgical OncologySpringer Journals

Published: May 31, 2018

References

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Search

Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly

Organize

Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.

Access

Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve

Freelancer

DeepDyve

Pro

Price

FREE

$49/month
$360/year

Save searches from
Google Scholar,
PubMed

Create lists to
organize your research

Export lists, citations

Read DeepDyve articles

Abstract access only

Unlimited access to over
18 million full-text articles

Print

20 pages / month

PDF Discount

20% off